Michigan Institute for Clinical and Health Research (MCHR)

2007年，CTSA对密歇根大学临床与健康研究所（MICHR）的资助标志着密歇根大学（UM）临床转化研究（CTR）转型的开始。这个奖项，加上强大的机构支持和不断增长的教师参与，使UM从一个主要的基础科学研究机构发展到一个具有全面的研究组合。这是在以下基础上实现的：已接触近2，000名学员，教职员工的综合创新培训和教育计划;集中和优化以前分散的研究服务，为用户创造创新机会;分配1020万美元用于试点研究，以加速创新;和研究人员参与与我们的社区和整个CTSA国家联盟的新伙伴关系。在更新期间，CTSA的资金与强大的机构支持相结合，将使MICHR能够实现5个总体目标：1）优化培训和指导，以创建下一代研究团队以及临床和转化研究人员; 2）增强基础设施并完善研究服务，以减少障碍并最大限度地提高整个转化研究连续体的研究生产力; 3）促进合作并利用创新方法和技术来促进发现; 4）加强基于社区和实践的伙伴关系，以确保双向学习，研究和实施有益于健康的发现; 5）积极领导和促进国家CTSA联盟活动，并参与跨CTSA合作。将通过以下方式实现这些目标：将教育扩展到新的领域，以加强CTR研究者的渠道，并部署更灵活的培训工具;加强现有服务并推出新服务，以影响研究启动时间和招募;利用重大信息学投资，将CTR研究者的需求完全融入IT环境;利用新的基于实践的研究网络;扩大评估，以有效评估和优化我们的绩效。MICHR将成为高质量，高影响力的临床和转化研究的改进和创新的引擎，以促进密歇根州和国家的健康。

The CTSA funding to the Michigan Institute for Clinical and Health Research (MICHR) in 2007 marked the beginning of a transformation of clinical-translational research (CTR) at the University of Michigan (UM). This award, coupled with strong institutional support and growing faculty engagement, enabled UM to evolve from a predominantly basic science research institution to one with a comprehensive research portfolio. This has been achieved on the foundation of: integrated and innovative training and educational programs that have touched nearly 2,000 trainees, faculty and staff; centralization and optimization of previously fragmented research services to create innovative opportunities for users; $10.2M distributed for pilot studies to accelerate innovation; and researcher participation in new partnerships with our communities and across the CTSA National Consortium. In the renewal period, CTSA funding leveraged with robust institutional support will enable MICHR to pursue 5 Overarching Objectives: 1) Optimize training and mentoring to create the next generation of research teams and clinical and translational investigators; 2) Augment infrastructure and refine research services to reduce barriers and maximize research productivity across the entire translational research continuum; 3) Foster collaborations and leverage innovative approaches and technologies to catalyze discovery; 4) Enhance community- and practice-based partnerships to assure bi-directional learning, research, and implementation of findings to benefit health; 5) Actively lead and contribute to national CTSA Consortium activities and engage in cross-CTSA collaborations. These will be achieved by: expanding education into new areas to strengthen the pipeline of CTR investigators and deploying more flexible training tools; strengthening existing services and launching new ones to impact study start-up times and recruitment; employing major informatics investments to fully integrate the needs of CTR investigators into IT landscape; utilizing new practice-based research networks; expanding evaluation to efficiently assess and optimize our performance. MICHR will be the engine of improvement and innovation in the conduct of high-quality, high impact-clinical and translational research to advance the health of Michigan and the nation.